{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:22Z","timestamp":1784751862164,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.biopsych.2012.07.011","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T00:45:53Z","timestamp":1345250753000},"page":"219-224","source":"Crossref","is-referenced-by-count":96,"title":["Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine \u03b2-Hydroxylase"],"prefix":"10.1016","volume":"73","author":[{"given":"Thomas R.","family":"Kosten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Lappalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.07.011_bib1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2012.07.011_bib2","series-title":"Results from the 2010 National Survey on Drug Use and Health (NSDUH). H-41 NS","year":"2011"},{"key":"10.1016\/j.biopsych.2012.07.011_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1520\/JFS2003221","article-title":"Methadone-related deaths in Palm Beach County","volume":"49","author":"Wolf","year":"2004","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.biopsych.2012.07.011_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0376-8716(94)01058-S","article-title":"Cocaine use and HIV risk behavior in methadone maintenance patients","volume":"37","author":"Bux","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.07.011_bib5","first-page":"205","article-title":"Factors associated with client-reported HIV infection among clients entering methadone treatment","volume":"9","author":"MacGowan","year":"1997","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.biopsych.2012.07.011_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0376-8716(94)90092-2","article-title":"HIV infection and cocaine use in methadone maintained and untreated intravenous drug users","volume":"36","author":"Meandzija","year":"1994","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.07.011_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2105\/AJPH.85.1.83","article-title":"Heroin use during methadone maintenance treatment: The importance of methadone dose and cocaine use","volume":"85","author":"Hartel","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.biopsych.2012.07.011_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02287318","article-title":"The long-term outcomes of drug use by methadone maintenance patients","volume":"30","author":"Bovasso","year":"2003","journal-title":"J Behav Health Serv Res"},{"key":"10.1016\/j.biopsych.2012.07.011_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00005053-198803000-00006","article-title":"Antecedents and consequences of cocaine abuse among opioid addicts","volume":"176","author":"Kosten","year":"1988","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2012.07.011_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v17n04_07","article-title":"Changes in HIV risk behaviors among cocaine-using methadone patients","volume":"17","author":"Magura","year":"1998","journal-title":"J Addict Dis"},{"key":"10.1016\/j.biopsych.2012.07.011_bib11","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1081\/JA-120016225","article-title":"Treating cocaine-using methadone patients: Predictors of outcomes in a psychosocial clinical trial","volume":"37","author":"Magura","year":"2002","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.biopsych.2012.07.011_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0306-4603(87)90042-6","article-title":"The effect of increased cocaine use on drug treatment","volume":"12","author":"Black","year":"1987","journal-title":"Addict Behav"},{"key":"10.1016\/j.biopsych.2012.07.011_bib13","first-page":"608","article-title":"Predicting cocaine use among methadone patients: Analysis of findings from a national study","volume":"43","author":"Dunteman","year":"1992","journal-title":"Hosp Community Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002950","article-title":"Antidepressants for cocaine dependence","author":"Lima","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2012.07.011_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003352.pub3","article-title":"Dopamine agonists for the treatment of cocaine dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database Sys Rev"},{"key":"10.1016\/j.biopsych.2012.07.011_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002023","article-title":"Carbamazepine for cocaine dependence","author":"Lima","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2012.07.011_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2012.07.011_bib19","first-page":"116","article-title":"Psychotherapeutic treatment of cocaine abuse: Models for its evaluation alone and in combination with pharmacotherapy","volume":"135","author":"Carroll","year":"1993","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.biopsych.2012.07.011_bib20","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0006-3223(99)00310-8","article-title":"Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: A preliminary trial","volume":"47","author":"George","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2012.07.011_bib22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.biopsych.2007.09.016","article-title":"The pharmacogenetics of major depression: Past, present, and future","volume":"62","author":"Laje","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib23","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1176\/appi.ajp.160.10.1830","article-title":"Pharmacogenetics of antidepressant medication intolerance","volume":"160","author":"Murphy","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1176\/appi.ajp.161.5.780","article-title":"Pharmacogenetics of psychotropic drug response","volume":"161","author":"Malhotra","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/appi.psy.47.1.75","article-title":"Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 and CYP450 2C19","volume":"47","author":"deLeon","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1016\/j.biopsych.2012.07.011_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0002-9343(02)01363-3","article-title":"Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs","volume":"113","author":"Rogers","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.biopsych.2012.07.011_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: Uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.278.5335.45","article-title":"Addiction is a brain disease, and it matters","volume":"278","author":"Leshner","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2012.07.011_bib29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1360-0443.2003.00438.x","article-title":"How important is treatment?","volume":"98","author":"Weisner","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2012.07.011_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.59.6.538","article-title":"A national 5-year follow-up of treatment outcomes for cocaine dependence","volume":"59","author":"Simpson","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib31","first-page":"91","article-title":"Emerging pharmacological strategies in the fight against cocaine addiction","volume":"11","author":"Sofuoglu","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.biopsych.2012.07.011_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/taap.1996.0147","article-title":"Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine","volume":"139","author":"Vaccari","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.biopsych.2012.07.011_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-005-0139-8","article-title":"Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice","volume":"183","author":"Bourdelat-Parks","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2012.07.011_bib34","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.npp.1301000","article-title":"Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine","volume":"31","author":"Schank","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.07.011_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0024-3205(73)90056-8","article-title":"Genetic control of plasma dopamine-beta-hydroxylase","volume":"12","author":"Ross","year":"1973","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2012.07.011_bib36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.181.4103.943","article-title":"Serum dopamine-beta-hydroxylase activity: Sibling-sibling correlation","volume":"181","author":"Weinshilboum","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2012.07.011_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-3956(86)90020-8","article-title":"Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals\u2014a genetic study","volume":"20","author":"Oxenstierna","year":"1986","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2012.07.011_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s004390050310","article-title":"Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals","volume":"99","author":"Wei","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.mp.4000657","article-title":"A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia","volume":"5","author":"Cubells","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s004390050736","article-title":"Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation","volume":"102","author":"Cubells","year":"1998","journal-title":"Hum Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/318198","article-title":"A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus","volume":"68","author":"Zabetian","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/375499","article-title":"The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity","volume":"72","author":"Zabetian","year":"2003","journal-title":"Am J Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0006-3223(02)01427-0","article-title":"A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function","volume":"52","author":"Kohnke","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10571-007-9256-8","article-title":"Correlation of plasma dopamine beta-hydroxylase activity with polymorphisms in DBH gene: A study on eastern Indian populaion","volume":"28","author":"Bhaduri","year":"2008","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2012.07.011_bib45","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1136\/jmg.2003.009282","article-title":"DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome","volume":"41","author":"Deinum","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00041444-199800810-00003","article-title":"TaqI polymorphic sites at the human dopamine beta-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia","volume":"8","author":"Wei","year":"1998","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-7138(10)60012-X","article-title":"Near-zero plasma dopamine-beta-hydroxylase and conduct disorder in emotionally disturbed boys","volume":"25","author":"Rogeness","year":"1986","journal-title":"J Am Acad Child Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004583-198403000-00013","article-title":"Clinical characteristics of emotionally disturbed boys with very low activities of dopamine-beta-hydroxylase","volume":"23","author":"Rogeness","year":"1984","journal-title":"J Am Acad Child Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib49","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0006-3223(87)90058-8","article-title":"Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys","volume":"22","author":"Rogeness","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004583-198801000-00019","article-title":"Diagnoses, catecholamine metabolism, and plasma dopamine-beta-hydroxylase","volume":"27","author":"Rogeness","year":"1988","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(91)90002-7","article-title":"Low dopamine-beta-hydroxylase: A biological sequela of abuse and neglect?","volume":"39","author":"Galvin","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.07.011_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-4-4","article-title":"Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers","volume":"4","author":"Jonsson","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients","volume":"168","author":"McLellan","year":"1980","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2012.07.011_bib54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archpsyc.1997.01830220041007","article-title":"Manual-guided psychosocial treatment","volume":"54","author":"Carroll","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/gte.2008.0068","article-title":"Quantitative fluorescent-PCR detection of sex chromosome aneuploidies and AZF deletions\/duplications","volume":"12","author":"Plaseski","year":"2008","journal-title":"Genet Test"},{"key":"10.1016\/j.biopsych.2012.07.011_bib56","series-title":"R: A Language and Environment for Statistical Computing","year":"2009"},{"key":"10.1016\/j.biopsych.2012.07.011_bib57","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1086\/501531","article-title":"Proportioning whole-genome single-nucleotide-polymorphism diversity for the identification of geographic population structure and genetic ancestry","volume":"78","author":"Lao","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2012.07.011_bib58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/genetics\/155.2.945","article-title":"Inference of population structure using multilocus genotype data","volume":"155","author":"Pritchard","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.biopsych.2012.07.011_bib59","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1755-0998.2009.02591.x","article-title":"Inferring weak population structure with the assistance of sample group information","volume":"9","author":"Hubisz","year":"2009","journal-title":"Mol Ecol Resour"},{"key":"10.1016\/j.biopsych.2012.07.011_bib60","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","article-title":"Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis","volume":"102","author":"Seeman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.07.011_bib61","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: A tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.07.011_bib62","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1073\/pnas.212519999","article-title":"Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals","volume":"99","author":"Weinshenker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.07.011_bib63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2006.08.016","article-title":"Disulfiram effects on responses to intravenous cocaine administration","volume":"87","author":"Baker","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.07.011_bib64","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0006-3223(94)00361-6","article-title":"Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans","volume":"37","author":"Hameedi","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0376-8716(98)00050-7","article-title":"Disulfiram effects on acute cocaine administration","volume":"52","author":"McCance-Katz","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.07.011_bib66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0006-3223(97)00506-4","article-title":"Chronic disulfiram treatment effects on intranasal cocaine administration: Initial results","volume":"43","author":"McCance-Katz","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-004-1840-8","article-title":"Human genetics of plasma dopamine beta-hydroxylase activity: Applications to research in psychiatry and neurology","volume":"174","author":"Cubells","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2012.07.011_bib68","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.1976.01770050047007","article-title":"Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia","volume":"33","author":"Meltzer","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib69","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0165-1781(86)90127-7","article-title":"Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression","volume":"19","author":"Mod","year":"1986","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.07.011_bib70","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1600-0447.1989.tb03008.x","article-title":"Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression","volume":"80","author":"Sapru","year":"1989","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.07.011_bib71","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1176\/ajp.151.3.372","article-title":"CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures","volume":"151","author":"van Kammen","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib72","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archpsyc.1983.01790060041005","article-title":"CSF dopamine beta-hydroxylase in schizophrenia","volume":"40","author":"Sternberg","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib73","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0006-3223(01)01349-X","article-title":"Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression","volume":"51","author":"Cubells","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.07.011_bib74","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm.2200","article-title":"Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis","volume":"16","author":"Yao","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2012.07.011_bib75","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.bjp.0701315","article-title":"Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase","volume":"121","author":"Stanley","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2012.07.011_bib76","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/npp.2010.127","article-title":"Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase","volume":"35","author":"Schroeder","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.07.011_bib77","article-title":"Dopamine hydroxylase inhibitor SYN117 decreases subjective effects of cocaine","author":"Cunningham","year":"2010"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312006233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312006233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T15:42:50Z","timestamp":1643211770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312006233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0006322312006233"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.07.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717954825.793462658","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717954825.793461805","asserted-by":"object"}]},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}